Australia New Zealand Food Standards Code – Standard 1.2.3 – Information requirements – warning statements, advisory statements and declarations

The Standard rests on a small number of interlocking legal ideas: mandated content by reference to external Code tables, threshold‑based advisory statements tied to ingredient levels, an enumerative regime for mandatory declarations using prescribed names, and typographical and positional controls designed to make required names and summary statements visually distinct.

Mandated content by cross‑reference, not free text, is a central concept. Section 1.2.3,2(1) does not itself list advisory statements, it imposes a duty where a food appears in Column 1 of the table in section S9,2, to use the corresponding advisory in Column 2. Similarly, section 1.2.3,4(3) makes the Division apply to foods listed in Column 1 of the table to section S9,3, and section 1.2.3,5 ties which name to use to the Column 3 or Column 4 entries in that same table. The Standard therefore delegates substantive identification of specific allergens, ingredients and advisory text to Schedules S9,2 and S9,3 elsewhere in the Code.

Threshold‑triggered labelling is a second concept. Section 1.2.3,2(2) prescribes a specific, quantitative trigger for a laxative advisory: where listed sugar alcohols or polyols occur at or above either 10 g per 100 g for one group (lactitol, maltitol, maltitol syrup, mannitol, xylitol) or 25 g per 100 g for another group (erythritol, isomalt, polydextrose, sorbitol), and rules for combinations are set out at 1.2.3,2(2)(c). The amendment at 1.2.3,2(2)(d) extends mandatory advisory coverage to foods with added D‑allulose if the food is one of an explicitly listed set. A threshold model links laboratory composition or formulation to a labelling obligation, converting analytical measurement or recipe formula into a compliance decision.

Mandatory declarations centred on a prescribed required name are the third concept. Where Division 3 applies, the required name must be used in the statement of ingredients or elsewhere according to section 1.2.3,5 and the method of stating is set out in 1.2.3,6. If the declaration is made in the statement of ingredients and the declared item is a processing aid, the words ‘processing aid’ must accompany the required name in the statement of ingredients, see 1.2.3,6(2)(a)(ii), and a summary statement must also be included on the label, see 1.2.3,6(2)(b) and the detailed formatting rules in 1.2.3,7.

Presentation controls are explicit. Section 1.2.3,7 requires required names in the statement of ingredients to be printed in a bold font that provides a distinct contrast with other text, and in a size of type not less than the size of the other text in the statement of ingredients. Required names must be listed separately for each ingredient that is or contains the relevant food, and be separate words where contained in an ingredient name. A summary statement must commence with the single word ‘Contains’, list the required names, contain no other words, appear in the same field of view as the statement of ingredients, be directly next to it and be distinctly separated, and be printed in the same typeface and size as any required name, and bold, see 1.2.3,7(3)-(5).

Definitions and cross‑references are material. The Standard inserts two defined terms (required name, size of type) in 1.2.3,1A, and relies on the labelling provisions in Standard 1.2.1 and the statement of ingredients provisions in Standard 1.2.4. It also recognises special labelling and compositional rules for foods for special medical purposes and special medical purpose products for infants, see the notes at 1.2.3,6(4) and the footnote referring to Division 4 of Standard 2.9.1.

Finally, the instrument includes detailed transitional arrangements for specific amendments, recorded in the compilation table and the Amendment History. Those arrangements set transition windows during which pre‑existing and post‑variation labelling may both be sold, and in some cases a post‑transition sell‑through period is specified, see the application and transitional provisions summarised after the main text and the Amendment History entries for instruments F2017L00585, F2021L00145, and F2024L01151.

Collectively, these concepts make labelling obligations highly prescriptive, linking specified ingredient identities and measured thresholds to precise labelling text and typographic presentation, with the result that compliance is a rules‑driven exercise of identifying whether a food appears in S9 tables, measuring or documenting ingredient content to the required threshold, and formatting labels to the prescribed standard.

The Standard primarily affects persons and entities involved in producing, packaging, labelling, importing or selling foods for retail sale where the food is subject to the Code’s labelling provisions. The instrument repeatedly frames obligations as applying “for the labelling provisions”, referencing Standard 1.2.1 and Standard 1.2.4 for the statement of ingredients, therefore the practical group affected is those who control the label content under the Code, which commonly include manufacturers, packagers, private‑label producers, brand owners, importers, and retailers who place food for sale.

• Food manufacturers and brand owners: They must assess formulations and ingredients against the lists referenced in S9,2 and S9,3, and must measure or verify ingredient levels where threshold tests are used, for example the polyol thresholds in 1.2.3,2(2). If a product contains royal jelly as an ingredient, the exact warning text at 1.2.3,3 is required on the label.

• Food labellers and packagers: Section 1.2.3,7 imposes typographic and layout obligations on how a required name appears within the statement of ingredients and how a summary statement is displayed. Label artwork and print runs must reflect the bolding, sizing and adjacency rules. Because the summary statement must be directly next to and distinctly separated from the statement of ingredients, label layout decisions and pack real estate are affected.

• Importers: Imported packaged foods distributed in Australia and New Zealand must comply with the Code as it applies in each jurisdiction. Note 1 explicitly recognises the Standard is made under the Food Standards Australia New Zealand Act 1991, and Note 2 records that the Code provisions that apply in New Zealand are incorporated or adopted under the Food Act 2014 (NZ), meaning importers into New Zealand must satisfy their local incorporation/adoption process.

• Food service and small businesses: The Standard’s obligations apply to “a food for sale” where the labelling provisions require a statement of ingredients, and there are cross‑references to Standard 1.2.4 and to specific exemptions under 1.2.4,2(2) and (3). Businesses that supply unpackaged foods, very small batch items, or foods that are exempt from a statement of ingredients under 1.2.4 may be outside some of these requirements, but must check the cross‑references. Section 1.2.3,6(3) expressly notes subsection 1.2.3,6(2) does not apply to foods for sale to which subsections 1.2.4,2(2) or 1.2.4,2(3) apply.

• Producers of specialised nutrition products: Section 1.2.3,6(4) requires certain declarations to be made with a different naming rule for foods for special medical purposes and special medical purpose products for infants, referencing paragraph 2.9.5,9(1)(d) and Division 4 of Standard 2.9.1. Accordingly, manufacturers of special medical purpose products and infant formulas must reconcile these cross‑referenced provisions.

• Businesses using processing aids or additives: The Standard requires that when a declared food is present as a processing aid or an ingredient/component of a processing aid, that fact must be signalled in the statement of ingredients by adding the words ‘processing aid’ after the required name, see 1.2.3,6(2)(a)(ii). This affects suppliers whose ingredient supply chains include processing aids or transfer traces, and obliges labelling of processing aids where their constituent materials are listed in S9,3 Column 1.

• Legal and compliance advisers, trade and regulatory affairs teams: The Standard’s prescriptive typographic and naming requirements mean compliance is an interplay between composition, supply chain documentation, and label design. The Amendment History and transitional provisions mean advisers must also manage timing risks when a variation is introduced, for example the P1044 Plain English Allergen Labelling Variation with a transition period specified in the application provisions.

The lists in section S9,2 and S9,3 determine the precise set of foods that attract declarations and advisory text. The Standard does not itself list every allergen or advisory text; those are in the referenced tables. Therefore, the practical coverage for any given business depends on whether its ingredients are included in S9,2 or S9,3. The amendments listed in the Amendment History show that the set of covered foods and the required presentations have changed over time, most recently with the insertion of D‑allulose‑related requirements in October 2024, so affected stakeholders must monitor changes to the S9 schedules and the application/transitional notes.

This Standard creates mandatory duties about content and presentation, and it defines limited rights that are largely procedural (for example, transitional rights to sell packaged goods labelled under an earlier version during confirmed transition windows). The duties are concrete and prescriptive, and the rights are primarily transitional or structural.

Primary duties

• Duty to include specified advisory statements, where applicable: Under 1.2.3,2(1), where a food is listed in Column 1 of the table in section S9,2, the corresponding advisory statement in Column 2 must appear. This requires cross‑checking the S9,2 table.

• Duty to include a laxative advisory at defined thresholds: Section 1.2.3,2(2) requires a specific advisory that “excess consumption may have a laxative effect” for foods containing specified polyols at thresholds of 10 g/100 g (lactitol, maltitol, maltitol syrup, mannitol, xylitol) or 25 g/100 g (erythritol, isomalt, polydextrose, sorbitol), and rules for mixtures at 1.2.3,2(2)(c). From amendment 233, 1.2.3,2(2)(d) requires the advisory for certain foods with added D‑allulose.

• Duty to include a royal jelly warning: Section 1.2.3,3 requires a prescribed warning text where royal jelly is present as an ingredient.

• Duty to declare specified foods: Section 1.2.3,4(1) requires a declaration when a food listed in Column 1 of the table to S9,3 (or a derivative) is present in a food for sale in any of the manners listed in 1.2.3,4(5) (ingredient, additive, processing aid). The duty is subject to the exceptions listed in 1.2.3,4(4), which remove coverage where the listed food is in Column 2 of S9,3, or where other exceptions apply.

• Duty to use the required name: Section 1.2.3,5 requires that the required name for a food listed in Column 1 of S9,3 be used as the name in the statement of ingredients (Column 3 names) and in all other cases the Column 4 names. Section 1.2.3,6(1) requires the declaration to be by stating that required name.

• Duty on presentation: Section 1.2.3,7 requires required names in the statement of ingredients to be bold and not smaller type than surrounding text, listed separately, and, where summary statements are required, start with ‘Contains’, be adjacent to the ingredients panel, and be printed in the same typeface and size and in bold. Processing aids must be identified as such in the statement of ingredients when they are the vehicle for a required declaration, see 1.2.3,6(2)(a)(ii).

Transitional and limited rights

• Transitional compliance window: Multiple entries in the application, saving and transitional provisions and in the Amendment History grant businesses a transition period during which products may comply with either the pre‑variation Code or the amended Code, but not a mix of both; see the transition provisions summarised after the main text and the Amendment History entries for amendments F2017L00585 (A’ment No. 169), F2021L00145 (A’ment No. 197), and F2024L01151 (A’ment No. 231). For example, the Plain English Allergen Labelling Variation (A’ment No. 197) provided a transition period from 25 February 2021 to 25 February 2024 with a specified post‑transition sell‑through period.

• Right to use singular or plural: Section 1.2.3,8 expressly permits a required name to be stated in singular or plural form as required, which is a drafting flexibility for label copy.

Procedural and cross‑reference duties

• Cross‑reference duties: The Standard frequently frames obligations “for the labelling provisions”, and it defers to Standards 1.2.1 and 1.2.4 for labelling and statement of ingredient rules. That creates a procedural duty to ensure labels meet the wider labelling regime in those Standards, not only Division 3.

Operational rights and constraints

• No discretion in wording or presentation: Where the Standard prescribes wording or presentation (for example the exact royal jelly warning text in 1.2.3,3, the ‘Contains’ only summary format in 1.2.3,7(3), and the bolding and type size rules in 1.2.3,7(1) and (5)), firms do not have discretion to paraphrase or alter the mandated language or format where the Standard applies. The right to use singular or plural in 1.2.3,8 is the only explicit linguistic flexibility in the required name context.

Key practical consequence: the Standard replaces commercial label judgements with rule‑based decisions. For an affected food business the primary compliance tasks are identifying whether ingredients are captured by the S9 lists, determining whether composition reaches numerical thresholds, and adapting label artwork to satisfy typographic and positional constraints. The Standard’s transitional provisions give time‑limited rights to use earlier labelling for existing stock, but the window periods and post transition sell‑through rules are specific to the amendment concerned, and must be followed exactly.

The Standard itself does not set criminal or civil penalties in its text. It is a Code instrument made under the Food Standards Australia New Zealand Act 1991, as stated in the instrument note. Enforcement mechanisms and penalties for non‑compliance with a food standard are therefore located in the parent legislation and in the jurisdictional food safety and fair trading laws that give effect to the Code. The Standard repeatedly frames its obligations “for the labelling provisions” and cross‑references Standards 1.2.1 and 1.2.4, which are labelling and statement of ingredients instruments that operate inside the Code framework. The immediate legal consequence is that the Standard creates mandatory obligations which authorised enforcement agencies may act upon under the enforcement powers granted by the relevant Acts and regulations.

What the source provides, and what it does not

• Provided: The instrument makes clear it is a Standard (Note 1), and it sets precise content and presentation obligations. It also documents its amendment history and transitional arrangements. These points identify the legal provenance and the temporal application rules that enforcement authorities will take into account.

• Not provided: This compilation does not state specific penalty amounts, infringement notice rates, or enforcement procedures. It also does not identify which particular enforcement authority will act in each case. Those matters are governed by the Food Standards Australia New Zealand Act 1991, by state/territory and New Zealand food legislation that incorporates or adopts the Code, and by enforcement policies and administrative instruments issued by those jurisdictions. For example, Note 2 indicates that the Code provisions that apply in New Zealand are incorporated in, or adopted under, the Food Act 2014 (NZ). The Standard itself therefore leaves the design of enforcement and sanctioning to the parent legislation and implementing jurisdictions.

Implementation and enforcement risks to stakeholders

• Administrative enforcement: Non‑compliance with the Standard may be pursued by state or territory food regulators or, in New Zealand, under the Food Act 2014, using the enforcement powers they possess under their respective laws. Those powers typically include directions to modify labels, detention or seizure of non‑complying goods, and prosecution or administrative penalties. The Standard’s transitional provisions mean that an enforcement action must consider whether a product was labelled during a permitted transition window, see the multiple transition entries in the application table and Amendment History. That creates a temporal compliance defence only where the product was packaged and labelled within an authorised transition period and sold within the permitted post‑transition sell‑through periods, where specified.

• Uncertainty where cross‑references apply: Several obligations depend on other Standards (1.2.1, 1.2.4, 2.9.1), which means enforcement risk depends on the combined interpretation of multiple instruments. Disputes as to whether a food is “present” as an ingredient, additive or processing aid, or whether a product falls within an exemption in 1.2.4,2(2) or (3), will affect whether Division 3 applies, and therefore whether regulators are likely to take action.

• Technical proof burdens: The laxative advisory thresholds in 1.2.3,2(2) convert compositional levels into labelling duties. Compliance and enforcement therefore require producers to either measure or demonstrate that ingredient levels are below thresholds, or else include the advisory. The need to maintain documentation and analytical evidence to defend labelling choices is an implementation cost.

Practical steps for businesses facing enforcement risk

• Maintain formulation records and supply chain documentation that show ingredient identities and concentrations, to support decisions under 1.2.3,2 and 1.2.3,4/5.

• Keep label change records and production dates to demonstrate whether a product was packaged or labelled during a permitted transition period where an amendment applied; the Amendment History entries set out explicit transition windows for specific variations.

• Seek early engagement with the appropriate regulator when labels are ambiguous or novel, because the Standard prescribes specific text and presentation styles; obtaining a regulator view or a formal determination under the parent Act can reduce compliance uncertainty.

In short, while the Standard gives precise substance and formatting rules, it leaves enforcement mechanics, penalty quantum and procedural machinery to the parent Act and jurisdictional enforcement frameworks. The Standard itself must be read and complied with as part of the broader regulatory enforcement landscape created by the Food Standards Australia New Zealand Act 1991 and equivalent New Zealand measures.

The Standard is not freestanding. It is embedded in the Australia New Zealand Food Standards Code and expressly cross‑references other Code Standards. Its legal effect and operational application therefore depend on interactions with the establishing Act and with related Code instruments.

Primary legal relationships in the text

• Food Standards Australia New Zealand Act 1991 (Cth): The Standard is a Code instrument under the Act, stated in Note 1. The Act is therefore the legal foundation that gives the Standard statutory force. The Standard does not itself reproduce enforcement or sanction provisions; those reside in the parent legislation and in jurisdictional acts which adopt and enforce the Code.

• Standard 1.2.1 (labelling provisions): The Standard repeatedly frames obligations “for the labelling provisions” and explicitly notes that the “labelling provisions are set out in Standard 1.2.1” in the notes following sections 1.2.3,2 and 1.2.3,3. This means that obligations under 1.2.3 interlock with the broader labelling requirements in 1.2.1. For instance, placement and field of view rules in 1.2.1 may influence how a summary statement required by 1.2.3,7 appears on pack.

• Standard 1.2.4 (statement of ingredients): Section 1.2.3,6 cross‑refers to the statement of ingredients provisions in Standard 1.2.4. That is material because the required name conventions in 1.2.3,5 differ depending on whether the declaration is made “in a statement of ingredients” (use Column 3 names) or in “all other cases” (use Column 4 names). The Standard also notes, at 1.2.3,6(3), that subsection 1.2.3,6(2) does not apply where subsection 1.2.4,2(2) or (3) applies, identifying specific circumstances where statement of ingredients obligations do not apply.

• Division 4 of Standard 2.9.1 and paragraph 2.9.5,9(1)(d): For foods for special medical purposes and special medical purpose products for infants, particular labelling and compositional requirements apply. Section 1.2.3,6(4) requires declarations for those products, and the accompanying notes reference paragraph 2.9.5,9(1)(d) and Division 4 of Standard 2.9.1. Those cross‑references mean producers of therapeutic or infant products must reconcile the mandatory declaration regime in 1.2.3 with the separate, specific labelling regime for such products.

• New Zealand Food Act 2014: Note 2 explains that provisions of the Code that apply in New Zealand are incorporated in, or adopted under, the Food Act 2014 (NZ). Therefore, operators in New Zealand must consider the way the Code has been integrated into domestic law; the operational effect can differ depending on whether the Code is incorporated or adopted, and on the New Zealand regulatory implementation.

Effects of cross‑references and delegation

• Delegation of substantive lists to Schedules S9,2 and S9,3: The Standard delegates which foods require advisory or declaratory text to the S9 schedules. That delegation means the Standard’s coverage can change without amending the text of 1.2.3 itself, by amending S9,2 or S9,3, subject to the normal Code amendment processes. Therefore stakeholders must monitor changes to S9 schedules as diligently as to 1.2.3.

• Interaction with statement of ingredient exemptions: Because 1.2.3,6(3) excludes application where subsections 1.2.4,2(2) or (3) apply, an exemption in 1.2.4 may remove the obligation to make summary statements or to use required names in certain products (for example, very small packages or some single‑ingredient foods). That creates an interaction where a product may be outside some duties under 1.2.3 only because it falls within an exemption in 1.2.4.

• Transitional and temporal interaction: The Amendment History and the application table record transitional arrangements for specific amendments, including different transition and post‑transition periods (for example, Amendment No. 197 P1044 had a transition from 25 February 2021 to 25 February 2024 and a separate post‑transition sell‑through period to 26 February 2026). The Standard’s interaction with other laws therefore requires businesses to track not only the operative text but also the temporal exceptions that allow dual compliance during specified windows.

Practical implications for compliance and legal advice

• Regulatory strategy must be multi‑instrument: Firms cannot assess compliance by reading 1.2.3 in isolation. They must check S9,2 and S9,3, Standards 1.2.1 and 1.2.4, applicable division 4 of 2.9.1 where relevant, and the parent Act and state food safety laws for enforcement regimes. The Standard itself signals this multi‑instrument approach via its repeated cross‑references and notes.

• New Zealand operators must verify local incorporation: The Note about the Food Act 2014 (NZ) means that Australian Code changes may require a different domestic adoption process in New Zealand; importers and New Zealand producers should confirm the local legal status of the Code and any time‑lag between Code amendments and domestic incorporation or adoption.

• Amendment pathways: Because S9 schedules carry the substantive lists, stakeholders should monitor FSANZ amendment proposals and gazetted variations that alter S9 tables. The Amendment History in the compilation shows this instrument has been varied multiple times (including adding definitions, inserting Division 3, and adding D‑allulose), demonstrating that substantive coverage can and does change.

In short, 1.2.3 must be read and applied as part of a network of Code instruments and implementing laws. Compliance decisions will depend on how the Standard interacts with S9 schedules, with Standard 1.2.4 statement of ingredient rules, with labelling rules in Standard 1.2.1, and with jurisdictional enforcement regimes created by the parent Act and domestic food laws.

The compilation includes a formal Amendment History summarising every amendment to Standard 1.2.3 up to Amendment No. 233 (compilation No. 6 as in force on 29 October 2024). The Amendment History is reproduced in the instrument and includes commencement details and short descriptions of the amendments. Key amendments recorded in the provided table are as follows, stated in the terms used in the source.

• Amendment No. 154 (F2015L00389), published in Food Standards Gazette No. FSC96 on 10 April 2015 and effective 31 March 2015, was the original publication of Standard 1.2.3. The compilation notes the Standard commenced on 1 March 2016 as recorded at the start of the instrument.

• Amendment No. 163 (FRL F2016L00783, FSC105, registered 12 May 2016, commenced 19 May 2016), amended 1.2.3,4(1) (references to cereals, milk and soybeans) and added subsection 1.2.3,4(3) to clarify application of subsection 1.2.3,4(1). The application table records the instrument and its transitional arrangements.

• Amendment No. 168 (FRL F2017L00414, FSC110, registered 11 April 2017, commenced 13 April 2017) made a minor textual amendment, inserting ‘or’ in 1.2.3,4(1)(b)(i)(B)(b).

• Amendment No. 169 (FRL F2017L00585, FSC112, registered 23 May 2017, commenced 25 May 2017) added subsection 1.2.3,1A(1) to establish a transitional arrangement associated with that variation, and added paragraph (b) to include lupin references in 1.2.3,4(1). The application table sets out a transition period from 25 May 2017 to 26 May 2018 for that variation, and 1.2.3,1A(3) provided that during that period food may comply with either the Code before variation or as amended by the variation, but not a combination.

• Amendment No. 197 (FRL F2021L00145, FSC138, registered 24 Feb 2021, commenced 25 Feb 2021) added Divisions 1-3 into the Standard and inserted definitions for ‘required name’ and ‘size of type’, see the Amendment History note that 1.2.3,4 through 1.2.3,8 were inserted by this amendment. Clause 4 of the instrument established a transition period for the variation from 25 Feb 2021 to 25 Feb 2024, and a post‑transition period from 26 Feb 2024 to 26 Feb 2026, with specified conditions on sale of goods labelled before the end of the transition period.

• Amendment No. 231 (FRL F2024L01151, FSC 171, registered 13 Sept 2024, commenced 13 Sept 2024) repealed and substituted paragraph 1.2.3,6(4)(b) and related notes, and inserted a transitional arrangement with a long transition period running from 13 Sept 2024 to 13 Sept 2029 for consequential amendments tied to Proposal P1028 - Infant Formula Products - Consequential Amendments.

• Amendment No. 233 (FRL F2024L01377, FSC173, registered 29 Oct 2024, commenced 29 Oct 2024) repealed and substituted paragraph 1.2.3,2(2)(c) and inserted paragraph 1.2.3,2(2)(d) to add text for D‑allulose. The Amendment History explicitly records that 1.2.3,2(2)(d) inserted text requiring the laxative advisory for foods with added D‑allulose that are specified types of food, effective 29 October 2024.

Accompanying application, saving and transitional provisions are recorded in a detailed table following the main text of the Standard. That table sets out the instrument items affected, amendment number, FRL registration and Gazette references, applicable clause in the instrument that establishes transitional arrangements, and a description of the transitional provisions. The compilation states it is No. 6 as in force on 29 October 2024, prepared by Food Standards Australia New Zealand on that date, and it states that uncommenced amendments or provisions ceasing to have effect may be reflected in the Standard as shaded text.

Practical effect of the Amendment History

• Temporal compliance windows matter. Several amendments create transition periods and post‑transition sell‑through windows. For example, Amendment No. 197 provides a transition 25 Feb 2021 to 25 Feb 2024 and an extended post‑transition sell‑through window to 26 Feb 2026 for goods labelled before the end of the transition period. Amendment No. 169 gave a one‑year transition period from 25 May 2017 to 26 May 2018. Amendment No. 231 sets a five‑year transition from 13 Sept 2024 to 13 Sept 2029 for the infant formula consequential amendments.

• Scope of amendments is concrete and specific. Amendments changed the Standard’s structure (inserting Divisions and defined terms), changed lists (adding lupin, adjusting references to cereals, milk and soybeans), and added new ingredient‑triggered advisories (D‑allulose). Businesses must track not only the main text but also the specific Amendment No., FRL code and commencement dates to understand rights to sell older‑labelled stock.

• The Amendment History in the compilation is authoritative for this Standard up to the stated compilation date. It should be consulted alongside the S9 schedules and other Standards for a complete compliance picture.

The compilation therefore provides both the present operative text and an audit trail of how key labelling obligations and structural features were introduced, amended, and temporally phased in.

The Standard text and its compilation do not include or list any litigation history, court decisions, or tribunal rulings. The instrument is an administrative Code standard and the compilation focuses on statutory text, cross‑references and amendment chronology. No cases, administrative determinations, or judicial interpretations are named or referenced in the document provided.

What that absence means for practitioners

• No source‑provided precedents: Because this compilation does not cite any judicial or tribunal decisions, readers cannot rely on the text to convey how courts or tribunals have interpreted particular phrases in the Standard, for example what constitutes a “derivative” of a food for the purposes of section 1.2.3,4(3), or how strictly courts will enforce the typographic and adjacency requirements of 1.2.3,7.

• Enforcement disputes likely resolved in administrative or civil venues: Disputes about compliance with the Standard will generally arise in enforcement or administrative contexts administered under the Food Standards Australia New Zealand Act 1991 and the implementing state or territory or New Zealand laws. Those disputes may involve directions to remove or remedy labels, consumer protection or fair trading claims, or prosecutions under implementing legislation. The absence of litigation entries in the compilation does not imply there has been no enforcement or litigation, only that none is recorded in this instrument.

• What to check outside the compilation: Practitioners should check jurisdictional decisions and reported cases in relevant courts and tribunals, regulator decisions, and interpretative guidance issued by FSANZ and state/territory regulators. FSANZ publishes compliance guidance, and enforcement agencies often publish policy or operational statements that provide insight into how labelling standards are enforced in practice. The Standard itself references other Code instruments and the parent Act; those instruments and the Act may have accompanying case law or administrative determinations relevant to interpretation.

Recommended actions for legal or compliance workstreams

• Search administrative decisions and enforcement outcomes: Where label wording, processing aid declarations, or threshold calculations are contested, search state and territory regulator enforcement notices, published recalls, case outcomes, and administrative determinations for precedents that interpret Code obligations.

• Record evidentiary posture: If a compliance decision must be defended, keep contemporaneous formulation data, analytical reports showing polyol or D‑allulose concentrations, supplier declarations about processing aids, and production and labelling dates to support claims that product labels complied with the applicable Code version and any transitional windows.

• Consider pre‑emptive regulatory engagement: Where the Standard leaves interpretative gaps (for example, the application of “derivative” or the borderlines of processing aid identification), proactive engagement with the regulator for a written compliance view may avoid later enforcement disputes.

In summary, the compilation contains no litigation history entries. Practitioners should therefore seek out external case law and regulator guidance to understand enforcement practice and judicial interpretation, and preserve documentary evidence in case an enforcement or dispute arises under the parent Act or implementing domestic laws.

The Standard is precise, but that precision creates practical pitfalls and traps for the unwary. This section highlights the specific points where businesses commonly make errors, or where the Standard’s drafting produces non‑obvious compliance outcomes. Each gotcha is tied to a section of the Standard.

1. Reliance on S9 tables rather than text in 1.2.3: Sections 1.2.3,2(1) and 1.2.3,4(3) delegate substantive coverage to S9,2 and S9,3. A common error is to read 1.2.3 as a self‑contained list. In practice you must check the S9 tables for exact entries, and those tables may be amended independently of 1.2.3. Don’t assume a food needs no label because it is not named in the 1.2.3 text block; check S9,2 and S9,3.

2. Threshold arithmetic and mixtures in 1.2.3,2(2)(a)-(c): The laxative advisory is triggered by specific concentration limits per 100 g. The rule distinguishes two groups of polyols with different thresholds (10 g/100 g for one group, 25 g/100 g for another), and a combination rule at 1.2.3,2(2)(c) which makes a combination count towards the lower 10 g/100 g threshold. Practically, that means formulators must aggregate contributions of different polyols and apply the combination rule. Errors include failing to convert between wet weight and recipe basis, or treating label declarations of ingredients as self‑evident rather than calculating actual concentrations.

3. D‑allulose carve‑in only for enumerated foods, 1.2.3,2(2)(d): The D‑allulose advisory introduced by Amendment No. 233 applies only where added D‑allulose is an ingredient and the food is one of an enumerated list (bakery product, bubble gum, chewing gum, breakfast cereal, confectionery but not chocolate, dessert, ice cream, edible ice, certain drinks, yoghurt). If D‑allulose is present in other foods, section 1.2.3,2(2)(d) does not by its text require the advisory. Misreading this can lead to unnecessary label statements or failure to include the advisory where required.

4. Processing aid labelling trap, 1.2.3,6(2)(a)(ii): If a declared food is present as a processing aid or is an ingredient of a processing aid, the statement of ingredients must include the required name and the words ‘processing aid’. A frequent misstep is to think processing aids never require ingredient disclosure; the Standard explicitly requires labelling where the processing aid contains a listed food and the Division applies.

5. Statement of ingredients exemptions interact with 1.2.3,6(3): Subsection 1.2.3,6(2) does not apply to foods that are exempt from a statement of ingredients under 1.2.4,2(2) or (3). That creates a conditional pathway where some small package or single‑ingredient foods may not need a summary statement, but the exemption criteria under 1.2.4 must be met. Misunderstanding the exemption scope leads to missing required declarations.

6. Presentation technicalities in 1.2.3,7: The Standard is strict about typography and adjacency. Required names must be bold and not smaller than the other ingredient text in the statement of ingredients, and summary statements must commence with exactly ‘Contains’ and contain no other words, appear in the same field of view and directly next to the statement of ingredients, and be distinctly separated. Common practical issues include label artwork that places summary statements on another panel, uses extra words in the summary statement (for example ‘Contains:’ followed by other wording), uses an italic or light bold that does not provide a distinct contrast, or uses smaller type for required names when trying to preserve brand layout. These are not drafting suggestions, they are mandated formatting choices; printers and designers must be briefed accordingly.

7. Required name selection per 1.2.3,5: The required name that must be stated depends on whether the declaration appears in the statement of ingredients or elsewhere. Section 1.2.3,5(a) and (b) refer to Column 3 or Column 4 of S9,3. Failing to use the correct column’s name results in a non‑conforming declaration.

8. Use of singular / plural flexible but limited, 1.2.3,8: The Standard expressly allows required names in singular or plural form, but this is the only explicit flexibility. Altering the required name to a synonym or local trade name without checking S9,3 is a mistake.

9. Transitional period timing and sell‑through allowances: The Amendment History and application table describe different transition windows for different amendments. For example, the P1044 amendment had a transition period to 25 February 2024 and a post‑transition sell‑through period to 26 February 2026. Businesses with older stock must ensure their packaging dates and sales routes fall squarely within permitted windows; otherwise a product may be non‑complying when sold after the transition close.

10. Special medical and infant product rules: Section 1.2.3,6(4) imposes a different naming duty for foods for special medical purposes and for special medical purpose products for infants. Those products are also subject to Division 4 of Standard 2.9.1. Misclassifying such products can either cause unnecessary compliance cost or lead to non‑compliance with specialist labelling obligations.

11. NZ incorporation caveat: Note 2 states that Code provisions that apply in New Zealand are incorporated in, or adopted under, the Food Act 2014 (NZ). Differences in domestic incorporation could produce timing or application differences; New Zealand importers should not assume identical domestic force and effect without checking the local adoption instrument.

12. Processing aid versus trace allergen questions: The Standard does not attempt to define every borderline concept inside its text, for example what constitutes a derivative or when cross‑contamination trace levels trigger a required declaration. Those determinations depend on S9 entries and the statement of ingredients rules, and may require regulator clarification or laboratory evidence.

These are the principal practical gotchas. The common theme is that the Standard couples substantive lists (located outside the body of the Division) with strict presentational rules, and a mix of thresholds, exceptions and transitional allowances. Compliance requires careful recordkeeping, label workflow controls, and attention to amendment timelines.

Compliance with Standard 1.2.3 is a two‑part exercise: (1) determine whether the Standard applies to the product, by checking S9,2 and S9,3 and relevant Code labelling provisions; and (2) where it applies, meet the content, naming and presentation rules exactly. Below are practical steps, with references to the relevant sections of the Standard.

1. Legal foundation check

• Confirm the product is a “food for sale” subject to the labelling provisions. The Standard’s obligations are framed “for the labelling provisions”, see the notes to sections 1.2.3,2 and 1.2.3,3. If your product falls into an exemption in Standard 1.2.4 (for example provisions in 1.2.4,2(2) or 1.2.4,2(3)), then parts of Division 3 may not apply; see 1.2.3,6(3). Verify the product category against Standards 1.2.1 and 1.2.4.

2. Check S9 lists and ingredient identity

• Review section S9,2: If your ingredient or product appears in Column 1 of S9,2, you must include the corresponding advisory statement from Column 2 on the label, as required by 1.2.3,2(1).

• Review section S9,3: If your ingredient or a derivative of it appears in Column 1 of S9,3, Division 3 applies to declare its presence in the situations listed in 1.2.3,4(5) (ingredient, additive, processing aid). If your ingredient appears in Column 2 of S9,3, Division 3 does not apply, see 1.2.3,4(4).

• Determine whether the ingredient is a derivative or component, as 1.2.3,4(3) and (4) hinge on this classification. If classification is unclear, document supplier information and consider pre‑emptive consultation with the regulator.

3. Quantitative triggers and analytical verification

• For polyol laxative advisory obligations, calculate concentrations on the correct basis and compare to thresholds at 1.2.3,2(2). The thresholds are: 10 g/100 g for lactitol, maltitol, maltitol syrup, mannitol, xylitol (1.2.3,2(2)(a)), 25 g/100 g for erythritol, isomalt, polydextrose, sorbitol (1.2.3,2(2)(b)), and combinations of the two groups are treated under 1.2.3,2(2)(c) as triggering at 10 g/100 g when one or more substances listed in (a) are combined with one or more from (b). From 1.2.3,2(2)(d) include the D‑allulose advisory where D‑allulose is added and the food is one of the enumerated types.

• Maintain analytical reports, formulation records and supplier declarations to document measured concentrations; this evidence will be necessary to justify omission of an advisory where composition is close to thresholds.

4. Statement of ingredients and required names

• Where Division 3 applies, determine the required name to use: if declaring within the statement of ingredients, use the corresponding name(s) in Column 3 of S9,3; for all other declarations use Column 4 names, per 1.2.3,5.

• If the declared item is present as a processing aid, include the required name plus the words ‘processing aid’ in the statement of ingredients, per 1.2.3,6(2)(a)(ii). Also, if the declaration is made in the statement of ingredients, include a summary statement on the label as required by 1.2.3,6(2)(b).

5. Formatting and placement

• Comply with typographic rules in 1.2.3,7. Required names in the statement of ingredients must be in a bold font that provides a distinct contrast with other text in that panel, and in a size of type not less than the other text in the statement of ingredients, per 1.2.3,7(1).

• Required names must be listed separately for each ingredient that is or contains the relevant food and be separate words where contained in the ingredient name, and listed next to but separately from the ingredient name unless identical or contained, per 1.2.3,7(2).

• If a summary statement is required, it must commence with the single word ‘Contains’, list the required names, contain no other words, and be placed in the same field of view as the statement of ingredients, directly next to it and distinctly separated. The summary statement must be printed in the same typeface and size as any required name in the statement of ingredients, and in bold, per 1.2.3,7(3)-(5).

• Ensure label designs are produced with these constraints in mind. Talk with designers and printers about how to achieve the “distinct contrast” requirement in practice and document proofs.

6. Processing aids and hidden sources

• Trace ingredients, processing aids and components can trigger declarations under 1.2.3,4(5)(b) and (c). Map your supply chain and ingredient lists carefully. If a processing aid or its ingredient contains a food listed in S9,3 Column 1, label accordingly and include ‘processing aid’ in the statement of ingredients, per 1.2.3,6(2)(a)(ii).

7. Special product categories

• For foods for special medical purposes and special medical purpose products for infants, follow the special naming rule in 1.2.3,6(4) and the cross‑referenced labelling/compositional rules in paragraph 2.9.5,9(1)(d) and Division 4 of Standard 2.9.1. Consult the standards for infant and medical purpose products where applicable.

8. Transitional and amendment timing

• Check the Amendment History and the application/transitional table for any amendments relevant to the product. If you packaged and labelled products before the end of a specified transition period, you may be permitted to sell them during a post‑transition period, see the transition notes for A’ment Nos. 169, 197, 231 and 233. Keep production date records to demonstrate compliance with transition windows.

9. Recordkeeping and audit trails

• Maintain formulation master records, supplier declarations, analytical test results, label proofs with production dates, and records of when packaging art was approved and printed. These will be essential in responding to regulator queries or enforcement action, particularly where thresholds or processing aids are in question.

10. Regulatory engagement and advice

• Where a borderland issue arises, such as whether a particular material is a derivative covered by S9,3 Column 1, or whether contamination trace levels require a declaration, engage early with the relevant regulator in writing to seek clarification. Obtain legal or regulatory advice for ambiguous cases. Document any regulator correspondence.

11. Packaging logistics

• For product runs straddling a change in the Code, ensure stock rotation and logistics planning align with permitted sell‑through rules and that distributors and retailers are aware of any changes and their compliance windows.

In practice, compliance is an operational discipline that combines product formulation knowledge, supply chain mapping, label design controls and document retention. The Standard’s prescriptive requirements for wording and typography mean legal compliance must be translated into production workflows and label proofs, not left to artwork judgement calls.